| Dr Todd David Daugherty, MD | |
|
168 Maple Street, Henniker, NH 03242 | |
| (603) 354-5400 | |
| Not Available |
| Full Name | Dr Todd David Daugherty |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 23 Years |
| Location | 168 Maple Street, Henniker, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639390776 | NPI | - | NPPES |
| 30207436 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 13580 (New Hampshire) | Primary |
| 207RR0500X | Internal Medicine - Rheumatology | 35.084570 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monadnock Community Hospital | Peterborough, NH | Hospital |
| Cheshire Medical Center | Keene, NH | Hospital |
| Catholic Medical Center | Manchester, NH | Hospital |
| Concord Hospital | Concord, NH | Hospital |
| Entity Name | Catholic Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972559904 PECOS PAC ID: 6103897129 Enrollment ID: O20060801000346 |
News Archive
The percentage of Hispanics in Texas without health insurance has dropped by 30 percent since the Affordable Care Act went into effect, but almost one-third of Hispanic Texans ages 18 to 64 remain uninsured.
Biopharmaceutical company Kiadis Pharma announces that it has successfully completed treatment of the last patient on its ATIR phase I/II clinical trial.
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
Despite the unpredictable economy, nearly three-quarters of New Jersey residents think spending money on research to improve health globally is important to jobs and incomes in the state, according to a new statewide poll commissioned by Research!America.
› Verified 2 days ago
| Entity Name | American Arthritis & Rheumatology Associates -nh Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871132019 PECOS PAC ID: 9436587888 Enrollment ID: O20200317002284 |
News Archive
The percentage of Hispanics in Texas without health insurance has dropped by 30 percent since the Affordable Care Act went into effect, but almost one-third of Hispanic Texans ages 18 to 64 remain uninsured.
Biopharmaceutical company Kiadis Pharma announces that it has successfully completed treatment of the last patient on its ATIR phase I/II clinical trial.
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
Despite the unpredictable economy, nearly three-quarters of New Jersey residents think spending money on research to improve health globally is important to jobs and incomes in the state, according to a new statewide poll commissioned by Research!America.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd David Daugherty, MD 590 Court St, Keene, NH 03431-1719 Ph: (603) 354-5454 | Dr Todd David Daugherty, MD 168 Maple Street, Henniker, NH 03242 Ph: (603) 354-5400 |
News Archive
The percentage of Hispanics in Texas without health insurance has dropped by 30 percent since the Affordable Care Act went into effect, but almost one-third of Hispanic Texans ages 18 to 64 remain uninsured.
Biopharmaceutical company Kiadis Pharma announces that it has successfully completed treatment of the last patient on its ATIR phase I/II clinical trial.
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
Despite the unpredictable economy, nearly three-quarters of New Jersey residents think spending money on research to improve health globally is important to jobs and incomes in the state, according to a new statewide poll commissioned by Research!America.
› Verified 2 days ago
Dr. Roger Elliott Belson, MD Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 14 Bridge St, Henniker, NH 03242 Phone: 603-428-3262 |